Selected Pharmaceutical Company Financials (Summary)
 Share
The version of the browser you are using is no longer supported. Please upgrade to a supported browser.Dismiss

 
View only
 
 
ABCDEFGHIJKLMNOPQRSTUVWXYZAAABACADAEAF
1
Companies2017 10-k (or Annual report)2017 Revenue2017 Cost of Goods2017 Marketing and Overhead2017 R&DR&D as share of revenueMarketing & Overhead as a share of revenueCost of goods as a percentageCoG, overhead, marketing and R&DR&D attributed to asset aquisistionsMisc notes
2
CountryCurrencyUSA
3
DenmarkDKKNovo Nordisk
https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2018/20180201_Financial%20statement_FY2017_UK.pdf
111,696 kr.32,124 kr.14,014 kr.12.5%28.8%41.3%
4
FranceEURSanofi
https://www.sanofi.com/media/Project/One-Sanofi-Web/sanofi-com/en/investors/docs/Sanofi-20-F-2017-EN-PDF-e-accessible_01.pdf
€35,055€11,611€10,058€5,47215.6%28.7%33.1%77.4%
5
IrelandUSDShire
http://investors.shire.com/~/media/Files/S/Shire-IR/documents/ar-2017/shire-annual-report-2017.pdf
$15,161$4,701$3,531$1,76311.6%23.3%31.0%65.9%
6
JapanYENAstellas
https://www.astellas.com/jp/system/files/4q2018_en.pdf
¥1,300,316¥294,250¥478,330¥220,78117.0%36.8%22.6%76.4%
7
SwedenUSDAstraZeneca
https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2017/annualreport2017.pdf
$22,465$4,318$10,233$5,75725.6%45.6%19.2%90.4%
8
SwissUSDNovartis
https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2017-en.pdf
$49,109$17,175$12,861$8,97218.3%26.2%35.0%79.4%
9
SwissCHFRoche
https://www.roche.com/dam/jcr:b70415c0-954f-4a2a-a0e2-47f94bd280e0/en/fb17e.pdf
CHF53,299CHF18,179CHF9,847CHF11,29221.2%18.5%34.1%73.8%
10
UKGBPGSK
https://www.gsk.com/media/4751/annual-report.pdf
£30,186£10,342£9,672£4,47614.8%32.0%34.3%81.1%
11
USUSDAbbVie
https://www.sec.gov/Archives/edgar/data/1551152/000155115218000014/0001551152-18-000014-index.htm
$28,216$7,040$6,275$4,98217.7%22.2%25.0%64.8%
12
USUSDBioGen
https://www.sec.gov/Archives/edgar/data/875045/000087504518000005/0000875045-18-000005-index.htm
$12,274$1,630$1,936$2,25418.4%15.8%13.3%47.4%
13
USUSDBMS
https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
$20,776$6,066$4,687$6,41130.9%22.6%29.2%82.6%$1.1 billion in asset acquisition costs assigned as R&D
7,700 people in R&D and related support activities,
14
USUSDCelgene
https://www.sec.gov/Archives/edgar/data/816284/000081628418000005/0000816284-18-000005-index.htm
$13,003$461$2,941$5,91545.5%22.6%3.5%71.7%
15
USUSDGilead
https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/0000882095-18-000008-index.htm
$26,107$4,371$3,878$3,73414.3%14.9%16.7%45.9%
16
USUSDMerck (US)
https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm
$40,122$12,775$9,830$10,20825.4%24.5%31.8%81.8%
17
USUSDPfizer
https://www.sec.gov/Archives/edgar/data/78003/000007800318000027/0000078003-18-000027-index.htm
$52,546$11,240$14,784$7,65714.6%28.1%21.4%64.1%
$295 million upfront payment to OPKO in the first quarter of 2015 associated with a worldwide development and commercialization agreement;
18
USUSDVertex
https://www.sec.gov/Archives/edgar/data/875320/000087532018000009/0000875320-18-000009-index.htm
$2,489$273$496$1,32553.2%19.9%11.0%84.1%
19
USUSD
Johnson & Johnson
https://www.sec.gov/Archives/edgar/data/200406/000020040618000005/0000200406-18-000005-index.htm
$76,450$25,354$21,420$10,55413.8%28.0%33.2%75.0%
20
USUSDAmgen
https://www.sec.gov/Archives/edgar/data/318154/000031815418000004/0000318154-18-000004-index.htm
$22,849$4,069$4,870$3,56215.6%21.3%17.8%54.7%
21
GermanyEURBayer
http://www.annualreport2017.bayer.com/downloads.html
€35,015€11,382€11,116€4,50412.9%31.7%32.5%77.1%
22
GermanyEUR
Boehringer Ingelheim
http://annualreport.boehringer-ingelheim.com/fileadmin/user_upload/BI_Annual_Report_2017_EN.pdf
€21,192€3,474€3,07814.5%0.0%16.4%30.9%
23
USUSD
Regeneron Pharmaceuticals Inc
https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm
$5,872$203$1,320$2,07535.3%22.5%3.4%61.3%
24
USUSDEli Lilly
https://investor.lilly.com/static-files/423887ae-38f3-463c-9d11-43088a30d68f
$22,871$6,070$6,588$5,28223.1%28.8%26.5%78.4%
25
USUSD
GE Healthcare (General Electric Company)
https://www.sec.gov/Archives/edgar/data/40545/000004054518000014/0000040545-18-000014-index.htm
$122,092$64,328$18,280$4,8033.9%15.0%52.7%71.6%
26
JapanYENEisai Inc
https://www.eisai.com/ir/library/settlement/pdf/e2017Q4_51.pdf
¥539,097¥195,905¥179,677¥112,47820.9%33.3%36.3%90.5%
27
JapanYEN
Takeda Pharmaceuticals
https://www.takeda.com/investors/reports/annual-reports/
Not reported
28
USUSDAlexion
https://www.sec.gov/Archives/edgar/data/899866/000089986618000022/0000899866-18-000022-index.htm
$3,551$454$1,094$87824.7%30.8%12.8%68.3%
29
UKUSD
Mallinckrodt Pharmaceuticals
https://www.sec.gov/Archives/edgar/data/1567892/000156789218000010/0001567892-18-000010-index.htm
$3,222$1,565$921$2778.6%28.6%48.6%85.8%
30
USUSDMylan
https://www.sec.gov/Archives/edgar/data/1623613/000162361318000010/0001623613-18-000010-index.htm
$11,908$7,125$2,576$7836.6%21.6%59.8%88.0%
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
Loading...
Main menu